Efficacy of a Habit Reversal Treatment on Tic-symptoms

March 14, 2017 updated by: Manfred Doepfner, University of Cologne

Within Subject Design on the Efficacy of Habit Reversal Treatment Programme in Children and Adolescents With Tics

The main purpose of this study is to evaluate the efficacy of a habit reversal based treatment programme in children and adolescents aged 8 to 18 years with tic disorders.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The main purpose of this study is to evaluate the efficacy of a habit reversal based treatment programme for children and adolescents with tic disorders. This habit reversal treatment programme was developed at the Department of Child and Adolescent Psychiatry and Psychotherapy at the University of Cologne and has already been evaluated in a pilot-study (Woitecki & Döpfner, 2011, 2012).

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cologne, Germany, 50931
        • Recruiting
        • University Hospital of Cologne, Department of Childhood and Adolescent Psychiatry and Psychotherapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 8-18 years
  • Diagnosis of chronic motor or vocal Tic (F95.1) or Tourette-Syndrome (F95.2)
  • YGTSS total score F95.2>13, F95.1>9
  • Tics are the main problems
  • IQ>80
  • If medication, then has been stable for at least one months in medicated patients
  • No change in medication treatment is planned
  • Ability to participate in weekly outpatient treatment
  • Acceptance of randomization

Exclusion Criteria:

  • Diagnosis of Autism Spectrum Disorder or Psychosis
  • Parallel continuous psychotherapy of tics or comorbid

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Habit Reversal Training
At first patients get informed about Tics in general. Then the individual Tics are specified and the tic-reaction is looked at further. The Tic-Symptoms are observed and the premonitory urge is specified. For all individual tics a specific reversal movement is developed. Relaxation methods are introduced.
awareness training, competing response training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Symptom Checklist for Tic-Symptoms (FBB-TIC), parent rating
Time Frame: Baseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)
The FBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents
Baseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Symptom Checklist for Tic-Symptoms (FBB-/SBB-TIC), Teacher-/self-rating
Time Frame: Baseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)
The SBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents
Baseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)
Change in Symptom Checklist for Tic-Symptoms, clinical rating
Time Frame: Baseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24 weeks (T3)
The Checklist is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by clinicians
Baseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24 weeks (T3)
Change of comorbid ADHD Symptoms (FBB/SBB-ADHD), parent, teacher and self-rating
Time Frame: T0, after 8 weeks (T1), 24weeks (T3)
The Symptom Checklist for Attention Deficit/Hyperactivity Disorder (FBB-/SBB-ADHS) assess all symptom criteria according to DSM IV and ICD-10.
T0, after 8 weeks (T1), 24weeks (T3)
Change of comorbid OCD Symptoms (ZWIK-E), parent-rating
Time Frame: T0, after 8 weeks (T1), 24 weeks (T3)
The ZWIK assess OCD criteria.
T0, after 8 weeks (T1), 24 weeks (T3)
Change of comorbid Symptoms (CBCL/TRF/YSR), parent-/teacher-/self-rating
Time Frame: T0, after 8weeks (T1), 24weeks (T3)
The CBCL, TRF and YSR assess a variation of different criteria.
T0, after 8weeks (T1), 24weeks (T3)
Change in Tic-Symptoms (YGTSS-TIC), overall score
Time Frame: Baseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)
The YGTSS is used to assess Tic-Symptoms in a semi structured interview with parents and patients
Baseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)
Change in Tic-Symptoms (observation)
Time Frame: Between T1 and T3 up to 16 weeks, during each session/week
Tic symptoms are observed through video tapes and are rated through clinicians.
Between T1 and T3 up to 16 weeks, during each session/week
Change in self-esteem (Harter-Scale-SBB)(self rating)
Time Frame: T0, after 8 weeks (T1), 24weeks (T3)
The Harter-Scale is used to assess self-esteem
T0, after 8 weeks (T1), 24weeks (T3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Anticipated)

August 1, 2017

Study Completion (Anticipated)

August 1, 2017

Study Registration Dates

First Submitted

April 14, 2014

First Submitted That Met QC Criteria

July 12, 2014

First Posted (Estimate)

July 15, 2014

Study Record Updates

Last Update Posted (Actual)

March 15, 2017

Last Update Submitted That Met QC Criteria

March 14, 2017

Last Verified

March 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tic-Disorder

Clinical Trials on Habit Reversal Training

3
Subscribe